Haima Therapeutics

company

About

Haima Therapeutics is a pre-clinical stage biotechnology company.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$300K
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Haima Therapeutics is a pre-clinical stage biotechnology company. It focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related ailments. It is developing platelet-inspired therapeutics to mitigate bleeding and treat other blood-related disorders where platelets play a key role in its progressions, such as thrombosis, inflammation, and cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$1.47M
Haima Therapeutics has raised a total of $1.47M in funding over 2 rounds. Their latest funding was raised on May 16, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 16, 2020 Grant $0.94M 1 National Science Foundation Detail
Jun 15, 2019 Grant $300K 1 National Institutes of Health Detail
Jan 1, 2018 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
3
2
Haima Therapeutics is funded by 2 investors. National Science Foundation and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
National Institutes of Health Yes Grant